In-Silico Capabilities

Research-Grade AI for Oncology

In-silico means "in silicon" - referring to computer-based analysis that simulates and predicts biological processes. Our research-grade AI platform transforms complex genomic data into actionable insights for oncology research and clinical decision support.

Research Use Only (RUO)

All outputs are for research purposes and not for diagnostic use. Built with transparent methodology and auditable provenance.

Available Now (Research-Mode)

Live capabilities with transparent evidence metrics, confidence scores, and auditable provenance

Live

Chemo Co‑Pilot: In‑Silico Chemotherapy Guidance

Core Capability

Evidence-backed chemotherapy recommendations with 70-85% confidence. See which drug classes match your patient's tumor biology with transparent S/P/E reasoning. Action-ready dossiers for same-day tumor board discussions.

Evidence (Core)

Confidence: Auditable Provenance

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Medical Oncologists

Learn More

Live

AgenticEMR™: Intelligent Clinical Data Management

Core Capability

Transform clinical data management by converting unstructured EMR data into structured, actionable clinical insights.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Clinical Oncologists

Learn More

Live

Oracle Intelligence: Multi-Modal AI Validation Platform

Core Capability

The S/P/E framework - where Sequence, Pathway, and Evidence combine for transparent, auditable variant predictions.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Clinical Oncologists

Learn More

Live

Forge Intelligence: Generative Therapeutic Design Platform

Core Capability

AI that designs precision therapeutics from first principles - CRISPR guides, protein inhibitors, and HDR templates engineered for efficacy.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Biotech Founders

Learn More

Live

Scribe Intelligence: Conversational AI Co-Pilot

Core Capability

Ask questions naturally, get evidence-backed answers. Progressive disclosure means you get exactly the level of detail you need - start simple and drill down when ready.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Oncologists

Learn More

Live

CRISPR Intelligence: Advanced Therapeutic R&D Platform

Core Capability

The definitive therapeutic design platform. Evo2-powered guide RNA design with AlphaFold 3 structural validation (pLDDT ≥70). 100% pass rate on validation benchmarks. IND package generation and IP monetization workflow included.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For R&D Scientists

Learn More

Live

Clinical Trials Co‑Pilot: In‑Silico Trial Matching

Core Capability

Which trials target YOUR tumor's vulnerabilities? We match your pathway burden (DDR, MAPK, PI3K) to trial drug mechanisms—not keywords. Action-ready dossiers for same-day enrollment.

Evidence (Core)

Confidence: Precision Oncology Matching

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Clinicians & Trial Offices

Learn More

Live

Immunotherapy Matching: Eligibility & Response Prediction

Core Capability

Predict immunotherapy eligibility and response using biomarker analysis. TMB, MSI, PD-L1, and tumor microenvironment analysis for precision immunotherapy selection.